Cancers, Vol. 16, Pages 1718: Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41

Conclusions: The use of HIPEC with gemcitabine after surgery in patients with resectable pancreatic ductal adenocarcinoma reduces locoregional recurrence and may be associated with a significant decrease in pancreatic cancer stem cells.

Source: Cancers - April 28, 2024 Category: Cancer & Oncology Authors: David Padilla-Valverde Raquel Bodoque-Villar Esther Garc ía-Santos Susana Sanchez Carmen Manzanares-Campillo Marta Rodriguez Lucia Gonz ález Alfonso Ambr ós Juana M. Cano Maria Padilla-Marcote Javier Redondo-Calvo Jesus Martin Leticia Serrano-Oviedo Tags: Article Source Type: research